Sociedad Americana de Hirudoterapia

[Coagulation Monitoring using ROTEM(®): Pro].

Research article published in Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS (2011)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosFries · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2011

Abstract

Coagulation and haemostasis in critical ill patients, either in massively bleeding patients in the emergency room and the operating theatre (TIC = trauma induced coagulopathy) or in septic patients suffering from multiorgan failure (DIC = disseminated intravascular coagulopathy) have to be identified and monitored promptly to initiate and monitor an effective therapy - either aggressive therapy using coagulation factor concentrates and blood products or a keen anticoagulation. Under this circumstances, standard coagulation monitoring using PT (INR), aPTT and fibrinogen (Clauss method) is limited. In critical ill patients, these parameters are neither able to predict risk of bleeding nor the risk of thrombosis. New viscoelastic methods like the ROTEM® may help to improve coagulation monitoring and management even in the emergency situation or under critical care conditions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal Article
Indexed MeSH termsBlood Coagulation DisordersEquipment DesignHumansThrombelastography

Resumen

[Coagulation Monitoring using ROTEM(®): Pro].

Por qué esto importa para la hirudoterapia

This article discusses the limitations of standard coagulation tests—PT (INR), aPTT, and fibrinogen by the Clauss method—in critically ill patients, noting that these parameters are neither able to predict risk of bleeding nor risk of thrombosis in massively bleeding or septic patients. The abstract states that new viscoelastic methods like ROTEM® may help improve coagulation monitoring and management in emergency situations and critical care conditions. The article addresses coagulation monitoring in trauma-induced coagulopathy and disseminated intravascular coagulopathy. The abstract contains no mention of leeches, hirudotherapy, hirudin, or the leech secretome, so any relevance to the American Society of Hirudotherapy is not supported by this article's content.

Citación

[Coagulation Monitoring using ROTEM(®): Pro].

Fries · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2011

DOI

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Clinical EvidenceClinical ApplicationsAnticoagulation CompoundsHemostasisDirect Thrombin InhibitorsOtolaryngology

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.